“Eligible patients may pay as little as $0 per one-month supply, subject to a maximum benefit.”
From the maker’s offer on bmsaccesssupport.com, checked November 17, 2026. Co-pay cards can’t be used with Medicare (including Medicare Advantage), Medicaid, TRICARE or VA.
Maker’s card or discount card?
A discount card like GoodRx lowers the pharmacy’s cash price, but for a brand-name drug that price often stays high. Compare it with the maker’s card above. You can usually use one or the other on a fill, not both.
Authorized generic
There isn’t one.
Not soldThere isn’t one
Regular generic
Same active ingredient as Pomalyst. Fillers and dyes can differ.
Cash priceAsk the pharmacyUsually the lowest
Who makes it
Makers and their savings cards
6 companies sell a generic of Pomalyst that the FDA rates a substitute. A pharmacy fills whichever one it stocks. 3 of them have their own savings cards or programs, listed first. Each works only with that maker’s version. To get a certain maker, ask for it by name; most pharmacies can order it in a day or two.
It’s mostly filled by specialty pharmacies. Your prescriber’s office or insurer can tell you which one to use.
Camber Copay Assistance Program (Camber Pharmaceuticals Co-Pay Program)
“To help alleviate the burden some drug prices create, Camber has made a copayment assistance program to help offset rising drug prices.” (patients not covered by any federal or state healthcare program (Medicare, Medicaid, Medigap, VA/DOD, TRICARE excluded); page says 'All non-excluded patients are eligible')
Who sells it: FDA and Medicaid records, updated weekly. Each maker’s page, card and program is from its own site, checked November 17, 2026. Co-pay cards can’t be used with Medicare (including Medicare Advantage), Medicaid, TRICARE or VA.
What to say at the pharmacy
“Before you fill my Pomalyst, can you tell me what I’d pay for the brand and for a generic?”
Paying cash? Ask for each one’s cash price. With insurance, ask what your plan charges for each.
POMALYST is a thalidomide analogue indicated for the treatment of adult patients:
in combination with dexamethasone, for patients with multiple myeloma (MM) who have received at least two prior therapies including lenalidomide and a proteasome inhibitor and have demonstrated disease progression on or within 60 days of completion of the last therapy.
with AIDS-related Kaposi sarcoma (KS) after failure of highly active antiretroviral therapy (HAART) or in patients with KS who are HIV-negative. This indication is approved under accelerated approval based on overall response rate. Continued approval for this indication may be contingent upon verification and description of clinical benefit in a confirmatory trial(s).
Source: the FDA label for Pomalyst (Celgene Corporation), February 26, 2025. Full label on DailyMed
Good to know
A regular generic may look different from Pomalyst. The FDA requires it to work the same way.
“Commercial insurance” means a plan from a job, from the marketplace, or one you buy yourself. A retiree plan that’s part of Medicare counts as Medicare. Co-pay cards can’t be used with Medicare (including Medicare Advantage), Medicaid, TRICARE or VA.
Most cards need a sign-up on the maker’s site, and many work only if your plan covers the drug. Then give the card’s details to your pharmacy.
Don’t stop or change a medicine without talking to your pharmacist or prescriber.
Prices checked November 17, 2026. Prices change: confirm with the pharmacy before you fill. drugalt.com/drug/pomalyst/